On July 6, 2021 and Aug 31, 2021, patents titled “Predicting response to immunotherapy using computer extracted features of cancer nuclei from hematoxylin and eosin (HandE) stained images of non-small cell lung cancer (NSCLC)” and “Sequential integration of adversarial networks with handcrafted features (SANwicH): identifying sites of prognostic significance for predicting cancer recurrence” were awarded to CCIPD.